Show simple item record

dc.contributor.authorChiesa, C
dc.contributor.authorSjogreen Gleisner, K
dc.contributor.authorFlux, G
dc.contributor.authorGear, J
dc.contributor.authorWalrand, S
dc.contributor.authorBacher, K
dc.contributor.authorEberlein, U
dc.contributor.authorVisser, EP
dc.contributor.authorChouin, N
dc.contributor.authorLjungberg, M
dc.contributor.authorBardiès, M
dc.contributor.authorLassmann, M
dc.contributor.authorStrigari, L
dc.contributor.authorKonijnenberg, MW
dc.date.accessioned2018-02-14T16:07:08Z
dc.date.issued2017-10
dc.identifier.citationEuropean journal of nuclear medicine and molecular imaging, 2017, 44 (11), pp. 1783 - 1786
dc.identifier.issn1619-7070
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1090
dc.identifier.eissn1619-7089en_US
dc.identifier.doi10.1007/s00259-017-3707-3en_US
dc.formatPrint-Electronic
dc.format.extent1783 - 1786
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectRadiopharmaceuticals
dc.subjectEmbolization, Therapeutic
dc.subjectRadiotherapy Dosage
dc.subjectRegistries
dc.subjectRadiation Dosage
dc.subjectNuclear Medicine
dc.subjectGovernment Regulation
dc.titleThe conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.
dc.typeJournal Article
dcterms.dateAccepted2017-04-16
rioxxterms.versionofrecord10.1007/s00259-017-3707-3
rioxxterms.licenseref.startdate2017-10en_US
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean journal of nuclear medicine and molecular imaging
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics/Radioisotope Physics (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics/Radioisotope Physics (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume44en_US
pubs.embargo.termsNot known
icr.researchteamRadioisotope Physicsen_US
dc.contributor.icrauthorFlux, Glennen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record